Tickerplace logo

Tickerplace

BetaShares Global Healthcare ETF - Currency Hedged logo

DRUGBetaShares Global Healthcare ETF - Currency Hedged

DRUG ETF | BetaShares Global Healthcare ETF - Currency Hedged Price, Market Cap & Holdings

Compare
$9.060+0.06 (+0.67%)

At close · 02 Sept 2026, 05:47 am

DRUG Historical price chart

DRUG Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization167.73M
PE Ratio24.57
EPS0.37
Trading Volume35.63K
Today's High/Low9.06/9.0
Dividend Yield4.02
52 Week High/Low9.27/7.64
Shares Outstanding18.51M

DRUG Company profile

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian…

DRUG Frequently asked questions

What is BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Stock Price?

Current stock price of BetaShares Global Healthcare ETF - Currency Hedged (DRUG) stock is $9.060. The stock price is +0.67% higher in the session. The intraday range can be seen from this page. Volume of BetaShares Global Healthcare ETF - Currency Hedged (DRUG) stock is 35.63K.

Last updated at 02 Sept 2026, 05:47 am.

Why is the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) stock price going up or down today?

The stock price of BetaShares Global Healthcare ETF - Currency Hedged (DRUG) can change with earnings, company news, and overall market sentiment. BetaShares Global Healthcare ETF - Currency Hedged operates in the Financial Services / Asset Management market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BetaShares Global Healthcare ETF - Currency Hedged stock expensive at its current price?

Whether BetaShares Global Healthcare ETF - Currency Hedged looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DRUG on this page is 24.57. EPS on this page is 0.37. Compare those figures with peers and growth expectations before deciding if the current BetaShares Global Healthcare ETF - Currency Hedged price is justified.

How has the stock price of BetaShares Global Healthcare ETF - Currency Hedged (DRUG) performed historically?

Historical performance for BetaShares Global Healthcare ETF - Currency Hedged (DRUG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DRUG reacted to past earnings and market events.

Should I buy BetaShares Global Healthcare ETF - Currency Hedged (DRUG) stock, at this price?

Buying BetaShares Global Healthcare ETF - Currency Hedged (DRUG) depends on your risk tolerance, time horizon, and portfolio needs. As a Financial Services name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.